D011355Chemicals & DrugsD26.675220.997897Prodrugscmhprofilesont:personsuffixperson suffixFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.2153130.2056482research area of0.8630660.09879925subject area for21145687Heemskerk AA, van Haandel L, Woods JM, McCance-Katz EF, Williams TD, Stobaugh JF, Faiman MDJournal of pharmaceutical and biomedical analysisHeemskerk AA, van Haandel L, Woods JM, McCance-Katz EF, Williams TD, Stobaugh JF, Faiman MD. LC-MS/MS method for the determination of carbamathione in human plasma. J Pharm Biomed Anal. 2011 Mar 25; 54(4):799-806.J Pharm Biomed Anal2010-11-02T00:00:002010LC-MS/MS method for the determination of carbamathione in human plasma.21162598Abdel-Rahman SM, Newland JG, Kearns GLPaediatric drugsAbdel-Rahman SM, Newland JG, Kearns GL. Pharmacologic considerations for oseltamivir disposition: focus on the neonate and young infant. Paediatr Drugs. 2011 Feb 01; 13(1):19-31.Paediatr Drugs2011-02-01T00:00:002011Pharmacologic considerations for oseltamivir disposition: focus on the neonate and young infant.9779765Kearns GL, Abdel-Rahman SM, Jacobs RF, Wells TG, Borin MTThe Pediatric infectious disease journalKearns GL, Abdel-Rahman SM, Jacobs RF, Wells TG, Borin MT. Cefpodoxime pharmacokinetics in children: effect of food. Pediatr Infect Dis J. 1998 Sep; 17(9):799-804.Pediatr Infect Dis J1998-09-01T00:00:001998Cefpodoxime pharmacokinetics in children: effect of food.1ProfessorPediatricsResearchClinicalPhD, MSAndreaGaedigkAndrea Gaedigk39.08346750000000-94.577112900000001Gaedigk, Andrea0000-0001-6968-1893Director, Pharmacogenetics Core LaboratoryMBBS, MRCPCHVenkateshSampathVenkatesh Sampath39.08346750000000-94.5771129000000044Sampath, VenkateshPhysician-ScientistChildren's Mercy Kansas City34126164Jaumotte JD, Franks AL, Bargerstock EM, Kisanga EP, Menden HL, Ghersi A, Omar M, Wang L, Rudine A, Short KL, Silswal N, Cole TJ, Sampath V, Monaghan-Nichols AP, DeFranco DBNeurobiology of diseaseJaumotte JD, Franks AL, Bargerstock EM, Kisanga EP, Menden HL, Ghersi A, Omar M, Wang L, Rudine A, Short KL, Silswal N, Cole TJ, Sampath V, Monaghan-Nichols AP, DeFranco DB. Ciclesonide activates glucocorticoid signaling in neonatal rat lung but does not trigger adverse effects in the cortex and cerebellum. Neurobiol Dis. 2021 08; 156:105422.Neurobiol Dis2021-06-11T00:00:002021Ciclesonide activates glucocorticoid signaling in neonatal rat lung but does not trigger adverse effects in the cortex and cerebellum.35034351Lee CR, Luzum JA, Sangkuhl K, Gammal RS, Sabatine MS, Stein CM, Kisor DF, Limdi NA, Lee YM, Scott SA, Hulot JS, Roden DM, Gaedigk A, Caudle KE, Klein TE, Johnson JA, Shuldiner ARClinical pharmacology and therapeuticsLee CR, Luzum JA, Sangkuhl K, Gammal RS, Sabatine MS, Stein CM, Kisor DF, Limdi NA, Lee YM, Scott SA, Hulot JS, Roden DM, Gaedigk A, Caudle KE, Klein TE, Johnson JA, Shuldiner AR. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update. Clin Pharmacol Ther. 2022 11; 112(5):959-967.Clin Pharmacol Ther2022-02-08T00:00:002022Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.true1Director, Pharmacogenetics Core LaboratoryDirector, Pharmacogenetics Core Laboratorytrue1Physician-ScientistPhysician-Scientist